Case Report: Management of recurrent UTI with tigecycline in a kidney transplant recipient

This case report describes a 37-year-old man who underwent renal transplantation and subsequently developed complicated recurrent urinary tract infections (UTIs) caused by multidrug-resistant (MDR) Klebsiella pneumoniae. Despite initial treatment with fosfomycin and meropenem, the patient experience...

Full description

Saved in:
Bibliographic Details
Main Authors: Supreeta R. Shettar, Mahadevaiah Neelambike Sumana, Manjunath S. Shetty, Yogeesh D. Maheshwarappa, Raghukanth G. Reddy, Asha Srinivasan, Vamshi Dharan P, Gautam Kalyatanda, Shruthi Shree S C
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Series:Frontiers in Transplantation
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/frtra.2024.1496702/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850087120870309888
author Supreeta R. Shettar
Mahadevaiah Neelambike Sumana
Manjunath S. Shetty
Yogeesh D. Maheshwarappa
Raghukanth G. Reddy
Asha Srinivasan
Vamshi Dharan P
Gautam Kalyatanda
Shruthi Shree S C
author_facet Supreeta R. Shettar
Mahadevaiah Neelambike Sumana
Manjunath S. Shetty
Yogeesh D. Maheshwarappa
Raghukanth G. Reddy
Asha Srinivasan
Vamshi Dharan P
Gautam Kalyatanda
Shruthi Shree S C
author_sort Supreeta R. Shettar
collection DOAJ
description This case report describes a 37-year-old man who underwent renal transplantation and subsequently developed complicated recurrent urinary tract infections (UTIs) caused by multidrug-resistant (MDR) Klebsiella pneumoniae. Despite initial treatment with fosfomycin and meropenem, the patient experienced persistent UTIs, leading to multiple hospitalizations. The management of these recurrent infections eventually required the use of tigecycline. Although tigecycline is not typically considered a urinary antibiotic owing to its limited urinary excretion, it was successfully employed in this case to manage the recurrent infections. The patient was treated with tigecycline for several episodes of UTI, which provided a crucial therapeutic option in the context of antibiotic resistance. This case underscores the challenges of managing recurrent MDR UTIs in immunocompromised patients and highlights tigecycline as an effective treatment strategy when standard therapies fail.
format Article
id doaj-art-4f57a2be2f7440e98c80a85dc7bd7f8b
institution DOAJ
issn 2813-2440
language English
publishDate 2025-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Transplantation
spelling doaj-art-4f57a2be2f7440e98c80a85dc7bd7f8b2025-08-20T02:43:16ZengFrontiers Media S.A.Frontiers in Transplantation2813-24402025-02-01310.3389/frtra.2024.14967021496702Case Report: Management of recurrent UTI with tigecycline in a kidney transplant recipientSupreeta R. Shettar0Mahadevaiah Neelambike Sumana1Manjunath S. Shetty2Yogeesh D. Maheshwarappa3Raghukanth G. Reddy4Asha Srinivasan5Vamshi Dharan P6Gautam Kalyatanda7Shruthi Shree S C8JSS Medical College and Hospital, JSS Academy of Higher Education and Research, Mysuru, IndiaJSS Medical College and Hospital, JSS Academy of Higher Education and Research, Mysuru, IndiaJSS Medical College and Hospital, JSS Academy of Higher Education and Research, Mysuru, IndiaJSS Medical College and Hospital, JSS Academy of Higher Education and Research, Mysuru, IndiaJSS Medical College and Hospital, JSS Academy of Higher Education and Research, Mysuru, IndiaDivision of Nanoscience and Technology, School of Life Sciences, JSS Academy of Higher Education and Research, Mysuru, IndiaJSS Medical College and Hospital, JSS Academy of Higher Education and Research, Mysuru, IndiaDivision of Infectious Disease and Global Medicine, University of Florida, Gainesville, FL, United StatesJSS Medical College and Hospital, JSS Academy of Higher Education and Research, Mysuru, IndiaThis case report describes a 37-year-old man who underwent renal transplantation and subsequently developed complicated recurrent urinary tract infections (UTIs) caused by multidrug-resistant (MDR) Klebsiella pneumoniae. Despite initial treatment with fosfomycin and meropenem, the patient experienced persistent UTIs, leading to multiple hospitalizations. The management of these recurrent infections eventually required the use of tigecycline. Although tigecycline is not typically considered a urinary antibiotic owing to its limited urinary excretion, it was successfully employed in this case to manage the recurrent infections. The patient was treated with tigecycline for several episodes of UTI, which provided a crucial therapeutic option in the context of antibiotic resistance. This case underscores the challenges of managing recurrent MDR UTIs in immunocompromised patients and highlights tigecycline as an effective treatment strategy when standard therapies fail.https://www.frontiersin.org/articles/10.3389/frtra.2024.1496702/fullmulti-drug resistant Klebsiella pneumoniaemultidrug-resistant organismsurinary tract infectionkidney transplantationimmunocompromised conditions
spellingShingle Supreeta R. Shettar
Mahadevaiah Neelambike Sumana
Manjunath S. Shetty
Yogeesh D. Maheshwarappa
Raghukanth G. Reddy
Asha Srinivasan
Vamshi Dharan P
Gautam Kalyatanda
Shruthi Shree S C
Case Report: Management of recurrent UTI with tigecycline in a kidney transplant recipient
Frontiers in Transplantation
multi-drug resistant Klebsiella pneumoniae
multidrug-resistant organisms
urinary tract infection
kidney transplantation
immunocompromised conditions
title Case Report: Management of recurrent UTI with tigecycline in a kidney transplant recipient
title_full Case Report: Management of recurrent UTI with tigecycline in a kidney transplant recipient
title_fullStr Case Report: Management of recurrent UTI with tigecycline in a kidney transplant recipient
title_full_unstemmed Case Report: Management of recurrent UTI with tigecycline in a kidney transplant recipient
title_short Case Report: Management of recurrent UTI with tigecycline in a kidney transplant recipient
title_sort case report management of recurrent uti with tigecycline in a kidney transplant recipient
topic multi-drug resistant Klebsiella pneumoniae
multidrug-resistant organisms
urinary tract infection
kidney transplantation
immunocompromised conditions
url https://www.frontiersin.org/articles/10.3389/frtra.2024.1496702/full
work_keys_str_mv AT supreetarshettar casereportmanagementofrecurrentutiwithtigecyclineinakidneytransplantrecipient
AT mahadevaiahneelambikesumana casereportmanagementofrecurrentutiwithtigecyclineinakidneytransplantrecipient
AT manjunathsshetty casereportmanagementofrecurrentutiwithtigecyclineinakidneytransplantrecipient
AT yogeeshdmaheshwarappa casereportmanagementofrecurrentutiwithtigecyclineinakidneytransplantrecipient
AT raghukanthgreddy casereportmanagementofrecurrentutiwithtigecyclineinakidneytransplantrecipient
AT ashasrinivasan casereportmanagementofrecurrentutiwithtigecyclineinakidneytransplantrecipient
AT vamshidharanp casereportmanagementofrecurrentutiwithtigecyclineinakidneytransplantrecipient
AT gautamkalyatanda casereportmanagementofrecurrentutiwithtigecyclineinakidneytransplantrecipient
AT shruthishreesc casereportmanagementofrecurrentutiwithtigecyclineinakidneytransplantrecipient